Description
Ubidecarenone USP 100mg + Lycopene (100%) USP 4000 mcg + Omega 3 Fatty Acid BP containing Eicosapentaenoic Acid 90 mg + Docosahexaenoic Acid 60 mg + L Arginine USP 100 mg + Selenium Dioxide IP 100 mcg U
Lycopene
Increased levels of LDL in plasma increases the risk of narrowing of lumen of artery also known as Arteriosclerosis which leads to restriction of blood flow. Hence, raising the risk of cardiovascular diseases. Lycopene decreases the LDL levels in blood plasma which in turn may help in cardiovascular diseases as per reports of clinical trials available in general public literature.
Ubidecarenone
CO Enzyme Q10 is an essential cofactor in the mitochondrial electron transport chain. Its functions are the acceptance of electrons from the complex I and II and this activity is vital for the production of ATP. It acts as a mobile redox agent shuttling electrons and protons in the electron transport chain. Ubidecarenone also presents antioxidant activity in mitochondria and cellular membranes, protecting against peroxidation of lipid membranes as well as inhibiting oxidation of LDL-cholesterol. CO Enzyme Q10 significantly improves endothelial function.
Selenium
It is a trace metal in the human body particularly important as a component of glutathione peroxidase, an important enzyme in the prevention of cellular damage by free radicals and reactive oxygen species.
Omega-3
L-arginine
L-arginine is an amino acid that helps the body build protein. It also releases nitric oxide into the blood. Nitric oxide acts to widen blood vessels in the bloodstream, which may help certain circulatory conditions, according to a 2016 review.
EPA i.e. ethyl eicosapentaenoic acid is a synthetic derivative of the omega-3 fatty acid eicosapentaenoic acid (EPA). It is used as an adjunct therapy for severe hypertriglyceridemia (TG levels > 500 mg/dL) and to reduce the risk of cardiovascular events in certain patients with elevated triglycerides.
The substance also stimulates the release of insulin into the body.
Docosahexaenoic acid (DHA) is an omega-3 fatty acid that is a primary structural component of the human brain, cerebral cortex, skin, and retina. The mechanism of action of DHA is attributed to the upregulation of the expression of B-secretase (BACE)2, which competed with BACE1 to cleave APP, thus decreasing the production of extracellular Amyloid beta that are the main component of the amyloid plaques found in the brains of people with Alzheimer’s disease.